Enable Biotech


ENABLE Biotech is a next-generation CDMO based in Switzerland aiming to address the unique needs of start-ups and spinouts in the area of advanced therapies. Our speciality is in the production of CAR-T therapies, stem cell therapies, gene-modified cell therapies, and exosome therapies. We provide a unique partnership model tailored to meet needs from development to Phase I/IIa trials, including supporting with CMC, process development, and clinical stage GMP manufacturing.